A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM)
Clinical trial NCT03199469 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03199469
- Sponsor
- Astellas Gene Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2021-09-09
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.